Personalised medicine in IBD: don’t dispose of the sledgehammer just yet-Reference-Cited by-同舟云学术

Personalised medicine in IBD: don’t dispose of the sledgehammer just yet

Published:2022-01 Issue: Volume:15 Page:175628482210925
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Kumar Aditi¹^ORCID,Brookes Matthew J²³,Segal Jonathan P⁴⁵^ORCID

Affiliation:

1. Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK

2. Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK

3. University of Wolverhampton Research Institute in Healthcare Sciences, Wolverhampton, UK

4. Department of Gastroenterology, Northern Hospital, Epping, Victoria, Australia

5. Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia

Funder

Astma och allergiförbundet

Hjärt-Lungfonden

Publisher

SAGE Publications

Subject

Gastroenterology

Link

http://journals.sagepub.com/doi/pdf/10.1177/17562848221092562

Reference13 articles.

1. National Cancer Institute. Definition of personalized medicine- NCI Dictionary of Cancer Terms, https://www.cancer.gov/publications/dictionaries/cancer-terms/def/personalized-medicine

2. The Distinctive Nature of HER2-Positive Breast Cancers

3. Personalising medicine in inflammatory bowel disease—current and future perspectives

4. Personalised medicine in Crohn's disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study;Journal of Gastrointestinal and Liver Diseases;2023-12-22